Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates

Figures & data

Table 1. Socio-demographic and medical characteristics of HCWs, UAE, January 2021

Variable	Frequency (N)	Percent (%)
Age group (Years)
45 and above	70	13.54
35–44	121	23.40
25–34	227	43.91
18–24	99	19.15
Gender
Female	330	63.83
Male	187	36.17
HCW profession
Physician	273	52.80
Nurse	51	9.86
Pharmacist/Laboratory HCWs	121	23.40
Others	72	13.93
Emirate
Abu Dhabi	101	19.54
Dubai	157	30.36
Sharjah	184	35.59
Other	75	14.51
Type of work setting
Private/Others	160	30.91
Public/ Government	242	46.81
University Hospital	115	22.24
Chronic medical conditions
No	442	85.49
Yes	75	14.51
Contact with COVID-19 patients
No	100	19.34
Yes	417	80.66
Had COVID-19 infection
No	461	89.17
Yes	56	10.83
Had Influenza shot
No	272	52.61
Yes	245	47.39
Total	517

Figure 1. Willingness to take the vaccine/give it to family and preferred timing of vaccine UAE, January 2021.

Table 2. Reasons cited for taking or not taking the COVID-19 vaccine among HCWs, UAE, January 2021

	Frequency	Percent
Reasons cited among those who want to take vaccine (N = 312)
Worried about contracting COVID-19 myself	146	46.79
Worried about my children/family members contracting COVID-19	208	66.67
Perceive myself as being high risk to develop complications from COVID-19	70	22.44
Feels sense of social responsibility to take the vaccine	199	63.78
Reasons cited among those who do not want to take vaccine (N = 205)
Inadequate data about the safety of vaccine	172	83.9
Already infected with COVID-19 so don’t need	17	8.29
Avoid vaccines/ medicines in general	31	15.12
Concerned about side effects	125	60.98
Concerned about the vaccine being ineffective	60	29.27
Prior adverse reaction to vaccines	16	7.8
Don’t perceive myself at high risk	32	15.61
Others	9	4.39

Figure 2. Knowledge and acceptance of type of vaccines among HCWs, UAE, January 2021.

Table 3. Predictors for HCWs taking the vaccine or giving it to family/children, UAE, January 2021

		Yes, I will take it		Yes, I will give it to my family/children
		aOR	95%CI	aOR	95%CI
Age	45 and above	1		1
	35–44	1.81	0.75,4.38	0.76	0.35,1.68
	25–34	0.92	0.41,2.05	0.69	0.33,1.45
	18–24	1.68	0.69,4.12	1.05	0.45,2.42
Gender	Female	1		1
	Male	2.34*	1.34,4.08	1.39	0.85,2.28
Had influenza shot	No	1		1
	Yes	2.13*	1.29,3.51	1.23	0.78,1.95
Knowledge about vaccines	Poor knowledge	1		1
	Good knowledge	1.55	0.95,2.53	1.31	0.83,2.06
Attitude about vaccine	Negative attitude	1		1
	Positive attitude	6.36*	3.67,11.02	6.72*	4.13,10.91
Reasons cited for taking COVID-19 vaccine
Inadequate data about the safety of vaccine	No	1		1
	Yes	0.17*	0.10,0.30	0.25*	0.16,0.42
Already infected with covid-19	No	1		1
	Yes	0.34	0.12,1.01	0.58	0.21,1.56
Avoid vaccines/ medicines in general	No	1		1
	Yes	0.30*	0.10,0.88	0.53	0.20,1.39
Concerned about side effects	No	1		1
	Yes	0.50*	0.29,0.88	0.65	0.38,1.10
Concerned about the vaccine being ineffective	No	1		1
	Yes	0.79	0.41,1.53	0.78	0.41,1.47
Prior adverse reaction to vaccines	No	1		1
	Yes	2.5	0.92,6.74	2.15	0.84,5.50
Don’t perceive myself at high risk	No	1		1
	Yes	0.11*	0.03,0.35	0.18*	0.06,0.54
Others	No	1		1
	Yes	0.19*	0.04,0.85	1.05	0.32,3.44
Pseudo R-squared		0.40		0.31

*indicates p-value <.05.

Table 4. Predictors for choice of Pfizer and Sinopharm among HCWs, UAE, January 2021

		Pfizer		Sinopharm
		aOR	95%CI	aOR	95%CI
Age	45 and above	1		1
	35–44	1.38	0.63,3.01	1.49	0.68,3.30
	25–34	0.94	0.45,2.00	0.61	0.27,1.37
	18–24	1.09	0.46,2.60	0.97	0.37,2.54
Gender	Female	1		1
	Male	1.85*	1.16,2.97	2.06*	1.21,3.52
Type of work setting	Private + other	1		1
	Public/ Government	2.02*	1.17,3.48	1.18	0.64,2.18
	University Hospital	1.03	0.54,1.95	1.08	0.52,2.24
Had influenza shot	No	1		1
	Yes	0.88	0.55,1.42	1.3	0.75,2.24
Has Chronic morbidity	No	1		1
	Yes	0.59	0.30,1.18	1.64	0.81,3.31
Attitude about vaccine	Negative attitude	1		1
	Positive attitude	3.70*	2.28,6.02	2.75*	1.55,4.88
Important factors for choosing COVID-19 vaccine type
This COVID-19 vaccine seems more reliable	No	1		1
	Yes	2.95*	1.76,4.95	1.04	0.59,1.85
This vaccine is available	No	1		1
	Yes	1.24	0.74,2.09	3.45*	2.00,5.95
Like the vaccine strategy/technology used	No	1		1
	Yes	0.75	0.46,1.22	0.93	0.53,1.63
Due to company’s reputation/Manufacturing country	No	1		1
	Yes	6.83*	4.18,11.14	0.54*	0.31,0.92
Less side effects from this vaccine	No	1		1
	Yes	0.43*	0.24,0.75	0.72	0.38,1.37
Media Coverage	No	1		1
	Yes	0.62	0.34,1.10	0.94	0.47,1.85
Personal preference	No	1		1
	Yes	0.98	0.58,1.66	0.74	0.39,1.43
Others	No	1		1
	Yes	0.77	0.32,1.83	1.16	0.47,2.86
Pseudo R-squared		0.27		0.18

*indicates p-value <.05.